National Health Determination under paragraph 98C(1)(b) Amendment 2017 (No. 8) (PB 110 of 2017) (Cth)

PB 110 of 2017

National Health Determination under paragraph 98C(1)(b) Amendment 2017
(No. 8)

_____________________________________________________________________

I, JULIANNE QUAINE, First Assistant Secretary (Acting), Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated 13 December 2017

JULIANNE QUAINE

First Assistant Secretary (Acting)

Technology Assessment and Access Division

Department of Health

1              Name of Instrument

(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2017 (No. 8).

(2)This Instrument may also be cited as PB 110 of 2017.

2              Commencement  

This instrument commences on 1 January 2018.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1            Amendments

1. Schedule 4, entry for Cromoglycic Acid

omit:

Eye drops containing sodium cromoglycate 20 mg per mL, 10 mL

1. Schedule 4, entry for Testosterone

omit:

Transdermal solution (pump pack) 30 mg per 1.5 mL dose, 60 doses